Rybelsus (semaglutide) has Food and Drug Administration (FDA) approval to manage blood sugar levels in adults with type 2 diabetes. Interested in learning more about it? You’re not alone—many people ...

The once-a-day semaglutide pill is approved for reducing the risk of heart disease and Type 2 diabetes, the company said in a ...

These meds are sometimes prescribed off-label for people with overweight or obesity. Most of these diabetes drugs promote weight loss by suppressing appetite and making you feel fuller. You might have ...

The FDA approved a pill version of the GLP-1 receptor agonist semaglutide (Wegovy), making it the first oral GLP-1 agent indicated for weight loss, Novo Nordisk announced on Monday. The once-daily 25 ...

GLP-1 RAs, particularly semaglutide and tirzepatide, outperform older medications in achieving significant weight loss in adults with and without type 2 diabetes. Semaglutide and tirzepatide met ...

Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. The pharmaceutical giant Eli Lilly announced last week that its ...

NEW DELHI — When the weight loss drug Mounjaro came on the market in India earlier this year, Shyamanthak Kiran was one of the first patients to try it. Kiran, a 27-year-old financial trader who has ...